Clinical Trials Browser

Phase EARLY_PHASE1 × Recruiting × Malignant Solid Tumors × Clear all

NCT05579275 2024-05-14

Evaluate the Safety and Tolerability of JCXH-212 Monotherapy and Combined With Toripalimab in the Treatment of Malignant Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Malignant Solid Tumors